Newron Pharmaceuticals S.p.A. – LSE:0QOI.L
Newron Pharmaceuticals S.p.A. stock price today
Newron Pharmaceuticals S.p.A. stock price monthly change
Newron Pharmaceuticals S.p.A. stock price quarterly change
Newron Pharmaceuticals S.p.A. stock price yearly change
Newron Pharmaceuticals S.p.A. key metrics
Market Cap | 159.36M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | -1.89 |
Revenue | 15.15M |
EBITDA | -24.75M |
Income | -33.71M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | -163.4% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeNewron Pharmaceuticals S.p.A. stock price history
Newron Pharmaceuticals S.p.A. stock forecast
Newron Pharmaceuticals S.p.A. financial statements
| Jun 2022 | 2.83M | -8.63M | -305.16% |
|---|---|---|---|
| Dec 2022 | 3.26M | -8.85M | -271.35% |
| Jun 2023 | 5.49M | -6.95M | -126.5% |
| Dec 2023 | 3.56M | -9.27M | -260.29% |
| 2025 | 25.74M | 5.36M | 20.83% |
|---|---|---|---|
| 2026 | 40.64M | 23.31M | 57.36% |
| 2027 | 116.25M | 61.43M | 52.85% |
| 2028 | 182.01M | 108.25M | 59.47% |
Analysts Price target
Financials & Ratios estimates
| Sep 2022 | 35962699 | 49.52M | 137.72% |
|---|---|---|---|
| Dec 2022 | 36824205 | 50.71M | 137.72% |
| Jun 2023 | 31494000 | 52.45M | 166.56% |
| Dec 2023 | 25866000 | 55.77M | 215.63% |
| Jun 2022 | -5.63M | -414K | -92K |
|---|---|---|---|
| Dec 2022 | -5.46M | 97K | -94K |
| Jun 2023 | -5.60M | -11K | -97K |
| Dec 2023 | -4.53M | 3.25M | -95K |
Newron Pharmaceuticals S.p.A. alternative data
| Aug 2023 | 23 |
|---|---|
| Sep 2023 | 23 |
| Oct 2023 | 23 |
| Nov 2023 | 23 |
| Dec 2023 | 23 |
| Jan 2024 | 23 |
| Feb 2024 | 23 |
| Mar 2024 | 22 |
| Apr 2024 | 22 |
| May 2024 | 22 |
| Jun 2024 | 22 |
| Jul 2024 | 22 |
Newron Pharmaceuticals S.p.A. other data
| Insider | Compensation |
|---|---|
Mr. Stefan Weber Chief Executive Officer & Executive Director | |
Mr. Roberto Galli Vice President of Fin. | |
Mr. Marco Caremi Executive Vice President of Bus. Devel. | |
Dr. Ravi Anand Chief Medical Officer |
-
What's the price of Newron Pharmaceuticals S.p.A. stock today?
One share of Newron Pharmaceuticals S.p.A. stock can currently be purchased for approximately $1.59.
-
When is Newron Pharmaceuticals S.p.A.'s next earnings date?
Unfortunately, Newron Pharmaceuticals S.p.A.'s (0QOI.L) next earnings date is currently unknown.
-
Does Newron Pharmaceuticals S.p.A. pay dividends?
No, Newron Pharmaceuticals S.p.A. does not pay dividends.
-
How much money does Newron Pharmaceuticals S.p.A. make?
Newron Pharmaceuticals S.p.A. has a market capitalization of 159.36M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 48.62% to 9.06M US dollars.
-
What is Newron Pharmaceuticals S.p.A.'s stock symbol?
Newron Pharmaceuticals S.p.A. is traded on the LSE under the ticker symbol "0QOI.L".
-
What is Newron Pharmaceuticals S.p.A.'s primary industry?
Company operates in the Healthcare sector and Medical - Pharmaceuticals industry.
-
How do i buy shares of Newron Pharmaceuticals S.p.A.?
Shares of Newron Pharmaceuticals S.p.A. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Newron Pharmaceuticals S.p.A.'s key executives?
Newron Pharmaceuticals S.p.A.'s management team includes the following people:
- Mr. Stefan Weber Chief Executive Officer & Executive Director
- Mr. Roberto Galli Vice President of Fin.
- Mr. Marco Caremi Executive Vice President of Bus. Devel.
- Dr. Ravi Anand Chief Medical Officer
-
How many employees does Newron Pharmaceuticals S.p.A. have?
As Jul 2024, Newron Pharmaceuticals S.p.A. employs 22 workers.
-
When Newron Pharmaceuticals S.p.A. went public?
Newron Pharmaceuticals S.p.A. is publicly traded company for more then 11 years since IPO on 17 Jun 2014.
-
What is Newron Pharmaceuticals S.p.A.'s official website?
The official website for Newron Pharmaceuticals S.p.A. is newron.com.
-
Where are Newron Pharmaceuticals S.p.A.'s headquarters?
Newron Pharmaceuticals S.p.A. is headquartered at Via Antonio Meucci 3, Bresso, MI.
-
How can i contact Newron Pharmaceuticals S.p.A.?
Newron Pharmaceuticals S.p.A.'s mailing address is Via Antonio Meucci 3, Bresso, MI and company can be reached via phone at +39 02 610 3461.
Newron Pharmaceuticals S.p.A. company profile:
Newron Pharmaceuticals S.p.A.
newron.comLSE
22
Medical - Pharmaceuticals
Healthcare
Newron Pharmaceuticals S.p.A., a clinical stage biopharmaceutical company, focuses on the research and development of therapies for the treatment of central and peripheral nervous system, and pain in Italy and the United States. The company offers Xadago (safinamide) for the treatment of Parkinson's disease, as well as develops Xadago for the treatment of levodopa induced dyskinesia. It also develops Evenamide for Schizophrenia and treatment resistant schizophrenia; and Ralfinamide for orphan indication in neuropathic pain. Newron Pharmaceuticals S.p.A. was founded in 1999 and is headquartered in Bresso, Italy.
Bresso, MI 20091
:
ISIN: IT0004147952
:
